Document is current
Any future updates will be listed below
-
Authors
Lee, Shawn H. R.
Yang, Wenjian http://orcid.org/0000-0002-7305-5649
Gocho, Yoshihiro
John, August http://orcid.org/0000-0003-4615-9474
Rowland, Lauren
Smart, Brandon
Williams, Hannah http://orcid.org/0000-0002-2082-7211
Maxwell, Dylan
Hunt, Jeremy
Yang, Wentao
Crews, Kristine R. http://orcid.org/0000-0002-7558-558X
Roberts, Kathryn G. http://orcid.org/0000-0001-7626-4043
Jeha, Sima
Cheng, Cheng
Karol, Seth E. http://orcid.org/0000-0001-8113-8180
Relling, Mary V. http://orcid.org/0000-0002-3720-9591
Rosner, Gary L. http://orcid.org/0000-0001-5566-6537
Inaba, Hiroto http://orcid.org/0000-0003-0605-7342
Mullighan, Charles G. http://orcid.org/0000-0002-1871-1850
Pui, Ching-Hon http://orcid.org/0000-0003-0303-5658
Evans, William E. http://orcid.org/0000-0002-9333-5322
Yang, Jun J. http://orcid.org/0000-0002-0770-9659
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (GM115279, GM141947, CA264837, CA264610, CA021765, GM115279, GM141947, CA264837, CA264610, CA021765)
American Lebanese Syrian Associated Charities
MOH | National Medical Research Council (003/008-258)
- License Information
-
More Information
Article History
Received: 4 April 2022
Accepted: 28 October 2022
First Online: 5 January 2023
Competing interests
: W.E.E. reports serving as a member of the scientific advisory board for Princess Maxima Centre for Childhood Cancer and serving as a board member for BioSkryb Genomics, neither of which pertain to the submitted work. C.G.M. reports receiving grants from Pfizer and AbbVie and personal fees from Amgen and Illumina outside the submitted work. J.J.Y. reports receiving research funding from Takeda Pharmaceutical Company outside the submitted work and having a patent pending for Methods for Determining Benefit of Chemotherapy. The other authors declare no competing interests.
